Cidara Therapeutics is celebrating a major injection of funding from the US government that will be used to support the development of its experimental preventive therapy for influenza. The sizeable ...
LA CROSSE (WKBT) -- 360 Real Estate offered updates to residents on the Copper Rocks residential project during a Bluffside Neighborhood Association meeting at Congregational Church Monday. The ...
Rafa Laboratories has received a potential $186 million contract from the Biomedical Advanced Research and Development Authority to develop an intramuscular formulation of tranexamic acid, or IM TXA, ...
Ginkgo Bioworks has been awarded a contract through the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium).
CAMBRIDGE, Mass., Nov. 3, 2025 /PRNewswire/ -- Start2 Group, Inc., a global leader in startup de-risking and acceleration, today announces its partnership with the Biomedical Advanced Research and ...
Hosted on MSN

Who is Big Barda?

Big Barda is a powerful and fierce superhero. Born on the planet Apocalypse she was taken from her parents by Darkseid, but left his oppressive regime and became a member of the Justice League, while ...
After reacquiring the rights to its non-vaccine flu preventative last year, Cidara Therapeutics has secured federal support to develop and produce the candidate, dubbed CD388, in the U.S. The ...
in funding by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response in the US Department of Health and Human Services.
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...
The two-part competition challenges innovators worldwide to develop high-performance, multiplexed antigen tests that are cost-effective, user-friendly, and capable of detecting priority pathogens in ...
ICON plc (NASDAQ:ICLR) has announced the suspension of its sponsor's next generation COVID vaccine study following a stop work notice from BARDA to the sponsor. The company's sponsor has ceased all ...
Cancel culture continues at the U.S. Department of Health and Human Services (HHS) as it observes National Immunization Awareness Month with another strike against vaccines. This time, a $500 million ...